TANVEER AHMAD

BRICK, NJ NPI 1962464495

General Payments — all program years on this page

$3,160.53

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 192
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $314.98 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $314.9817

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $528.7031
2019 $569.8635
2020 $379.4323
2021 $748.9146
2022 $507.9435
2023 $110.715
2024 $314.9817

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078091502 Janssen Pharmaceuticals, Inc $17.97 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078091510 Janssen Pharmaceuticals, Inc $20.07 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078091594 Janssen Pharmaceuticals, Inc $15.93 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086763139 Novartis Pharmaceuticals Corporation $17.32 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086763145 Novartis Pharmaceuticals Corporation $14.65 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092264442 Boston Scientific Corporation $25.98 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101406135 E.R. Squibb & Sons, L.L.C. $13.28 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108579181 Novo Nordisk Inc $16.56 09/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110542535 AstraZeneca Pharmaceuticals LP $14.16 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110546969 AstraZeneca Pharmaceuticals LP $15.41 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110548948 AstraZeneca Pharmaceuticals LP $13.26 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120648476 Baxter Healthcare $26.96 08/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120648478 Baxter Healthcare $31.18 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131078177 PFIZER INC. $14.50 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131407026 PFIZER INC. $15.61 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151799058 Chiesi USA, Inc. $26.06 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154870796 Kiniksa Pharmaceuticals International, plc $16.08 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.